A rising concern in the UK’s healthcare landscape is the emergence of a fast-spreading and often drug-resistant fungal infection known as Candida auris (C. auris). This infection, described by experts as an “overlooked killer”, has been present in parts of the country since 2019. The fungus has the potential to cause severe illness, with certain strains showing resistance to multiple drugs, making treatment challenging.
According to Dr. David Perlin, a renowned expert on fungi and Chief Scientific Officer at Hackensack Meridian Health Center for Discovery and Innovation in the US, C. auris differs from typical pathogens as it can survive well both outside the body and on various surfaces, including hospital equipment and the skin. The resilient nature of the fungus, combined with its tendency to be drug-resistant, poses a significant threat to public health.
C. auris primarily spreads in healthcare settings, such as hospitals or long-term care facilities, making individuals with underlying health conditions or compromised immune systems particularly vulnerable to infections. The fungus can manifest in various forms, including ear infections, wound infections, urinary tract infections (UTIs), and bloodstream infections that may lead to systemic illness.
Notably, a new variant of C. auris was recently identified in Singapore, raising global concerns among the scientific community. Despite no reported cases in Scotland, Public Health Scotland has issued guidance for the investigation, management, and prevention of C. auris infections. In England, between 2013 and 2021, a total of 304 C. auris isolates were reported through laboratory surveillance.
Recognising the symptoms of C. auris is crucial for early detection and appropriate management. While some infected individuals may not display symptoms, common signs include fever, chills, lethargy, low blood pressure, increased heart rate, and localized pain or pressure. Given the potential for asymptomatic carriers to spread the infection, prompt identification and intervention are essential in preventing further transmission.
In light of the growing threat posed by C. auris, healthcare providers and public health agencies in the UK must remain vigilant in monitoring and controlling its spread. Effective infection control measures, along with heightened awareness among healthcare professionals and the public, are critical in combating this escalating public health issue.